Oncology

Featured Research

Inhibiting MEK Protein Shrinks NF1 Plexiform Tumors After five other medications fail, selumetinib becomes first to demonstrate lasting improvement. In some ways, the impressive results from a clinical trial published in The New England Journal of  Medicine mark the triumph of a scientific career.

Read Featured Research

Division Summary

Research and Training Details

Faculty26
Joint Appointment Faculty3
Research Fellows and Post Docs6
Research Graduate Students4
Total Annual Grant Award Dollars$2,428,147
Total Annual Industry Award Dollars$851,654

Clinical Activities and Training

Staff Physicians8
Clinical Fellows8
Inpatient Encounters1,266
Outpatient Encounters14,793